Clinical Trial Update: A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 dose-finding study of PF-00337210, an investigational drug designed to decrease blood supply to tumors; results were posted in March …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PF-00337210

Snippet

Sponsor: Pfizer | Conditions: Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2013-03-19